Assessing the cost-effectiveness of adding aprepitant to the ASCO standard for prophylaxis of chemotherapy induced nausea and vomiting

Susan G. Moore,John W. Tumeh,S. Wojtanowski,Christopher R. Flowers

Assessing the cost-effectiveness of adding aprepitant to the ASCO standard for prophylaxis of chemotherapy induced nausea and vomiting

2005

Susan G. Moore
John W. Tumeh
S. Wojtanowski
Christopher R. Flowers

6009 Background: Chemotherapy-induced nausea and vomiting (CINV) is cited as a great concern for cancer patients. ASCO guidelines for prophylaxis of CINV in patients receiving highly-emetogenic che...

Keywords:

Aprepitant
Anesthesia
Chemotherapy-induced nausea and vomiting
Medicine
Nausea
Cancer
cost effectiveness
Vomiting
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations